B of A Securities analyst George Staphos downgrades Boise Cascade (NYSE:BCC) from Neutral to Underperform.
Eloxx Pharmaceuticals Plans To Take ELX-02 Into Pivotal Trial For Alport Syndrome
Eloxx Pharmaceuticals Inc (NASDAQ:ELOX) intends to advance ELX-02 into a pivotal trial for treating Alport syndrome with nonsense mutations…